Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

CUSIP: 984241109

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
45,101,565
Total 13F shares
24,348,906
Share change
+1,346,441
Total reported value
$294,136,627
Put/Call ratio
1.6%
Price per share
$12.08
Number of holders
95
Value change
+$14,837,664
Number of buys
49
Number of sells
49

Security key

984241109

Report period

Q2 2024

Institutions

95

Top holders

10

Ownership snapshot

Top shareholders of YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with the largest verified stakes, then open the linked filing trail.

Lead holder
13D/G signal
Evidence rows
0
Latest as of
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
95
Shares
24,348,906
Rows loaded
96
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
94
Q2 2024 holders
95
Holder diff
1
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .